Symbotic Aktie: Bereit für die nächste große Aufwärtswelle?
1 extracted signal · 0 resolved · 1 still active
MCO Global AktienIndependent analyst profile- Source published
- 07 Sept 2026, 14:14 UTC
- Recorded by Tahlil Plus
- 07 Sept 2026, 15:31 UTC
AI-generated source summary
The analysis focuses on Symbiotic Inc. (SYM) using a daily timeframe and Elliott Wave Theory. The stock has completed a five-wave impulse move and is currently in a corrective phase, possibly a WXY or a complex WXYXZ pattern. The current price is around $42.94. A key support zone is identified between $23.25 and $37.12. The analysis suggests that a potential bottom might be forming within this zone, supported by bullish divergence on the RSI. The ideal scenario for a bullish continuation would be a bounce off the support zone and a break above the descending channel. A projected target for the next wave is around $61.80 (1.618 extension), and a more ambitious long-term target is near $106.00 (first wave extension). The invalidation level for this bullish outlook is set below $16.36, which represents the low of the first wave. The speaker also mentions a potential target of $37.00 (100% extension of C wave) for a short-term bullish move.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
MCO Global Aktien
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.